Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
BackgroundNon-vitamin K antagonist oral anticoagulants (NOACs) showed a benefit-risk profile superior to that of warfarin in atrial fibrillation (AF) patients with mild to moderate chronic kidney disease. However, the effectiveness and safety of NOACs in AF patients with end-stage renal disease (ESR...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2022-09-01
|
| Seri Bilgileri: | Frontiers in Cardiovascular Medicine |
| Konular: | |
| Online Erişim: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.1005742/full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|